PMPRB update: Revised compliance timelines for grandfathered and gap medicines and proposed regulatory amendments directed to CSPs
By EsqSocial Corporation 30/04/21
Revised compliance timelines for Grandfathered and Gap medicines - On April 16, 2021, in view of COVID-19, the Patented Medicine Prices Review Board (PMPRB) reversed its position on compliance timelines for Grandfathered and Gap medicines: compliance with the Maximum List Price for these medicines will now be assessed after two filing periods... In the result, the operative date for assessing compliance for Grandfathered and Gap Medicines with the amendments coming into force on July 1, 2021...
By: Smart & Biggar